Ticagrelor-Mono- or NOAK/P2Y12 according to DES-PCI: Less is more

被引：0
|
作者：
Franke, Katharina
机构：
来源：
AKTUELLE KARDIOLOGIE | 2020年 / 9卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：14 / +
页数：2
相关论文
共 50 条
  • [1] Ticagrelor: the first novel reversible P2Y12 inhibitor
    Htun, Wah Wah
    Steinhubl, Steven R.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (02) : 237 - 245
  • [2] P2Y12 inhibitor monotherapy after coronary stenting according to type of P2Y12 inhibitor
    Kim, Juwon
    Jang, Woo Jin
    Lee, Wang Soo
    Choi, Ki Hong
    Lee, Joo Myung
    Park, Taek Kyu
    Yang, Jeong Hoon
    Choi, Jin-Ho
    Bin Song, Young
    Choi, Seung-Hyuk
    Gwon, Hyeon-Cheol
    Lee, Sang Hoon
    Oh, Ju-Hyeon
    Chun, Woo Jung
    Park, Yong Hwan
    Im, Eul-Soon
    Jeong, Jin-Ok
    Cho, Byung Ryul
    Oh, Seok Kyu
    Yun, Kyeong Ho
    Cho, Deok-Kyu
    Lee, Jong-Young
    Koh, Young-Youp
    Bae, Jang-Whan
    Choi, Jae Woong
    Yoon, Hyuck Jun
    Lee, Seung Uk
    Cho, Jang Hyun
    Choi, Woong Gil
    Rha, Seung-Woon
    Hahn, Joo-Yong
    [J]. HEART, 2021, 107 (13) : 1077 - 1083
  • [3] P2Y12 RECEPTOR INHIBITION ACCORDING TO PREHOSPITAL ADMINISTRATION OF TICAGRELOR IN PRIMARY PCI FOR ST ELEVATION MYOCARDIAL INFARCTION: THE PRIVATE-ATLANTIC STUDY
    Silvain, Johanne
    Storey, Robert
    Cayla, Guillaume
    Esteve, Jean-Baptiste
    Dillinger, Jean-Guillaume
    Vicat, Eric
    Collet, Jean-Philippe
    Tsatsaris, Anne
    Baradat, Caroline
    Salhi, Nejoua
    Lapostolle, Frederic
    Lassen, Jens
    Hamm, Christian
    Van't Hof, Arnoud
    Montalescot, Gilles
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A221 - A221
  • [4] Ticagrelor: a P2Y12 antagonist for use in acute coronary syndromes
    Wijeyeratne, Yanushi Dullewe
    Joshi, Rashi
    Heptinstall, Stan
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2012, 5 (03) : 257 - 269
  • [5] Efficacy and Safety of Ticagrelor: A Reversible P2Y12 Receptor Antagonist
    Anderson, Shawn D.
    Shah, Niren K.
    Yim, Juwon
    Epstein, Benjamin J.
    [J]. ANNALS OF PHARMACOTHERAPY, 2010, 44 (03) : 524 - 537
  • [6] When Less Becomes More: Insights on the Pharmacodynamic Effects of Aspirin Withdrawal in Patients With Potent Platelet P2Y12 Inhibition Induced by Ticagrelor
    Capodanno, Davide
    Angiolillo, Dominick J.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (24):
  • [7] Hirudin anticoagulation allows more rapid determination of P2Y12 inhibition by the VerifyNow P2Y12 assay
    Sumaya, Wael
    Daly, Rebecca L.
    Mehra, Sonal
    Dhutia, Amrita J.
    Howgego, Kate E.
    Ecob, Rosemary
    Judge, Heather M.
    Morton, Allison C.
    Storey, Robert F.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2013, 109 (03) : 550 - 555
  • [8] Ticagrelor: The First Reversibly Binding Oral P2Y12 Receptor Antagonist
    Husted, Steen
    van Giezen, J. J. J.
    [J]. CARDIOVASCULAR THERAPEUTICS, 2009, 27 (04) : 259 - 274
  • [9] Deciphering biased inverse agonism of cangrelor and ticagrelor at P2Y12 receptor
    Cédric Garcia
    Agnès Maurel-Ribes
    Michel Nauze
    Du N’Guyen
    Laurent O. Martinez
    Bernard Payrastre
    Jean-Michel Sénard
    Céline Galés
    Véronique Pons
    [J]. Cellular and Molecular Life Sciences, 2019, 76 : 561 - 576
  • [10] Deciphering biased inverse agonism of cangrelor and ticagrelor at P2Y12 receptor
    Garcia, Cedric
    Maurel-Ribes, Agnes
    Nauze, Michel
    N'Guyen, Du
    Martinez, Laurent O.
    Payrastre, Bernard
    Senard, Jean-Michel
    Gales, Celine
    Pons, Veronique
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2019, 76 (03) : 561 - 576
12345